Proof in Practice: Documented Interventions Drive Member Adherence
A 2025 outcomes analysis of pharmacy-delivered interventions, from Pharmacy Quality Solutions (PQS), an Innovaccer company.
A 2025 outcomes analysis from Pharmacy Quality Solutions (PQS), an Innovaccer company. The white paper examines whether documented pharmacist interventions, delivered through PQS's LAMP (Longitudinal Adherence Monitoring Program), actually improve medication adherence among health plan members.
The data, drawn from over 680,000 member/measures across 550,000 patients, shows that members who received a documented pharmacy intervention ended the year with meaningfully better adherence than those who did not: a 3.34-point gain in average PDC and a 6.7 percentage point increase in patients crossing the 80% adherence threshold that CMS uses for Star Ratings. The program operates through a network of 47,000+ community pharmacies nationwide, making the pharmacist the most accessible and trusted touchpoint along a patient's care journey.
Bottom line: When pharmacists document their interventions, adherence improves in a measurable, verifiable way, and PQS has the data to prove it.
Proof in Practice: Documented Interventions Drive Member Adherence
A 2025 outcomes analysis of pharmacy-delivered interventions, from Pharmacy Quality Solutions (PQS), an Innovaccer company.
A 2025 outcomes analysis from Pharmacy Quality Solutions (PQS), an Innovaccer company. The white paper examines whether documented pharmacist interventions, delivered through PQS's LAMP (Longitudinal Adherence Monitoring Program), actually improve medication adherence among health plan members.
The data, drawn from over 680,000 member/measures across 550,000 patients, shows that members who received a documented pharmacy intervention ended the year with meaningfully better adherence than those who did not: a 3.34-point gain in average PDC and a 6.7 percentage point increase in patients crossing the 80% adherence threshold that CMS uses for Star Ratings. The program operates through a network of 47,000+ community pharmacies nationwide, making the pharmacist the most accessible and trusted touchpoint along a patient's care journey.
Bottom line: When pharmacists document their interventions, adherence improves in a measurable, verifiable way, and PQS has the data to prove it.
Proof in Practice: Documented Interventions Drive Member Adherence
A 2025 outcomes analysis of pharmacy-delivered interventions, from Pharmacy Quality Solutions (PQS), an Innovaccer company.
A 2025 outcomes analysis from Pharmacy Quality Solutions (PQS), an Innovaccer company. The white paper examines whether documented pharmacist interventions, delivered through PQS's LAMP (Longitudinal Adherence Monitoring Program), actually improve medication adherence among health plan members.
The data, drawn from over 680,000 member/measures across 550,000 patients, shows that members who received a documented pharmacy intervention ended the year with meaningfully better adherence than those who did not: a 3.34-point gain in average PDC and a 6.7 percentage point increase in patients crossing the 80% adherence threshold that CMS uses for Star Ratings. The program operates through a network of 47,000+ community pharmacies nationwide, making the pharmacist the most accessible and trusted touchpoint along a patient's care journey.
Bottom line: When pharmacists document their interventions, adherence improves in a measurable, verifiable way, and PQS has the data to prove it.
.png)
.jpg)
.png)
.png)